Peter Wijngaard - 18 May 2021 Form 4 Insider Report for Hepion Pharmaceuticals, Inc. (HEPA)

Role
Director
Signature
/s/ Peter Wijngaard
Issuer symbol
HEPA
Transactions as of
18 May 2021
Transactions value $
$0
Form type
4
Filing time
20 May 2021, 16:37:22 UTC
Next filing
20 Sep 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HEPA Stock Options Award $0 +200,000 +333% $0.000000 260,000 18 May 2021 Common Stock 200,000 $1.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.